YIDU TECH (02158) Affiliate Wins Bid for Infectious Disease Big Data Platform Project of the First Affiliated Hospital of Xi'an Jiaotong University, Involving RMB 14.945 Million
YIDU TECH (02158) announced that recently, the company's affiliate Yidu Cloud (Beijing) Technology Co., Ltd. successfully won the bid for the infectious disease intelligent early warning system, infectious disease surveillance and epidemiological investigation virtual simulation training center, and infectious disease big data platform project of the First Affiliated Hospital of Xi'an Jiaotong University College of Medicine, with a total project amount of approximately RMB 14.945 million.
YIDU TECH (02158) announces that recently, the company's affiliate Yidu Cloud (Beijing) Technology Co., Ltd. successfully won the bid for the infectious disease intelligent early warning system, infectious disease surveillance and epidemiological investigation virtual simulation training center, and infectious disease big data platform project of the First Affiliated Hospital of Xi'an Jiaotong University College of Medicine, with a total project amount of approximately RMB 14.945 million.
YIDU TECH is a core force driving the intelligent upgrade of China's healthcare system. The group deeply empowers the entire industry chain of "medical care, pharmaceuticals, insurance, and patients" with intelligent decision-making, and is committed to making precision medicine accessible to everyone. By simulating doctors' clinical decision-making logic, using real disease progression as training targets, and repeatedly validating in the real world, the group has built "AI that truly understands diseases" and provides measurable value to key links in the healthcare ecosystem: enabling doctors to have more precise and efficient decision-making tools, enabling pharmaceutical companies to shorten the distance from molecules to patients, enabling patients to enjoy more affordable precision diagnosis and treatment, and enabling public systems to obtain more scientific support. YIDU TECH, with independently innovated system-level intelligence, creates a more resilient, more caring, and more inclusive and efficient healthcare future.
Related Articles

LEADS BIOLABS-B (09887) Core Product Vilixin Granted Orphan Drug Designation in Japan
.png)
PARKSON GROUP (03368) entered into a lease agreement for the property located at Zijin Plaza, Mianyang City.

Policy bottom + valuation rebound, has the real estate industry reached a turning point?
LEADS BIOLABS-B (09887) Core Product Vilixin Granted Orphan Drug Designation in Japan

PARKSON GROUP (03368) entered into a lease agreement for the property located at Zijin Plaza, Mianyang City.
.png)
Policy bottom + valuation rebound, has the real estate industry reached a turning point?






